High dose antigen treatment with a peptide epitope of myelin basic protein modulates T cells in multiple sclerosis patients. [electronic resource]
Producer: 20130402Description: 10-5 p. digitalISSN:- 1090-2163
- CD4 Lymphocyte Count
- Clonal Anergy -- drug effects
- Compassionate Use Trials
- Dose-Response Relationship, Immunologic
- Follow-Up Studies
- Humans
- Immunotherapy
- Interferon-gamma -- blood
- Interleukin-17 -- blood
- Interleukin-2 Receptor alpha Subunit -- analysis
- Multiple Sclerosis, Chronic Progressive -- drug therapy
- Myelin Basic Protein -- administration & dosage
- Peptide Fragments -- administration & dosage
- T-Lymphocytes, Regulatory -- drug effects
- Transforming Growth Factor beta -- blood
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.